Sinopharm Group Co. Ltd. (HKG:1099)
15.36
-0.14 (-0.90%)
Sep 11, 2026, 4:08 PM HKT
Sinopharm Group Revenue
Sinopharm Group had revenue of 142.03B CNY in the quarter ending June 30, 2026, a decrease of -1.63%. This brings the company's revenue in the last twelve months to 571.92B, down -0.68% year-over-year. In the year 2025, Sinopharm Group had annual revenue of 575.17B, down -1.60%.
Revenue (ttm)
571.92B CNY
Revenue Growth
-0.68%
P/S Ratio
0.07
Revenue / Employee
6.32M CNY
Employees
90,447
Market Cap
48.37B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 575.17B | -9.34B | -1.60% |
| Dec 31, 2024 | 584.51B | -12.06B | -2.02% |
| Dec 31, 2023 | 596.57B | 44.42B | 8.05% |
| Dec 31, 2022 | 552.15B | 31.10B | 5.97% |
| Dec 31, 2021 | 521.05B | 64.64B | 14.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Charmacy Pharmaceutical | 5.40B |
| ETHK Labs | 3.35B |
| Sinco Pharmaceuticals Holdings | 2.22B |
| Sipai Health Technology | 1.83B |
| ClouDr Group | 1.57B |
| 160 Health International | 784.99M |
| Ziyuanyuan Holdings Group | 423.08M |
| Wanjia Group Holdings | 165.39M |
Sinopharm Group News
- 18 days ago - Sinopharm Group Earnings release: Q2 2026 - Filings
- 18 days ago - Sinopharm Group Slides: Q2 2026 - Filings
- 4 months ago - Sinopharm Group Earnings release: Q1 2026 - Filings
- 5 months ago - Sinopharm Group Earnings release: Q4 2025 - Filings
- 5 months ago - Sinopharm Group Slides: Q4 2025 - Filings
- 5 months ago - Sinopharm Group Annual report: Q4 2025 - Filings
- 10 months ago - Sinopharm Group Earnings release: Q3 2025 - Filings
- 6 years ago - Here Are All the COVID-19 Vaccines Currently in Clinical Testing - The Motley Fool